Risk factors for chronic renal dysfunction in cardiac allograft recipients

被引:33
|
作者
Esposito, C
Semeraro, L
Bellotti, N
Fasoli, G
Fornoni, A
Rampino, T
Klersy, C
Campana, C
Gavazzi, A
Viganò, M
Dal Canton, A
机构
[1] Univ Pavia, IRCCS, Policlin San Matteo, Dept Internal Med & Nephrol, I-27100 Pavia, Italy
[2] Univ Pavia, IRCCS, Policlin San Matteo, Div Cardiol, I-27100 Pavia, Italy
[3] Univ Pavia, IRCCS, Policlin San Matteo, Div Cardiac Surg, I-27100 Pavia, Italy
[4] Univ Pavia, IRCCS, Policlin San Matteo, Sci Adm, I-27100 Pavia, Italy
来源
NEPHRON | 2000年 / 84卷 / 01期
关键词
cardiac allograft recipients; renal function; heart transplantation; ciclosporin;
D O I
10.1159/000045534
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal dysfunction is one of the most common and threatening complications in heart transplant recipients. Even if ciclosporin seems to play a central role in inducing renal damage, other factors may concur or predispose to renal injury. In order to identify factors responsible for renal dysfunction, we retrospectively studied a cohort of 114 cardiac transplant recipients during a follow-up period of at least 3 years. The patients had a normal renal function before and 0.5 months after heart transplantation. Doubling of baseline serum creatinine or attainment of serum creatinine steadily above 176.8 mu mol/l (2.0 mg/dl) was used as criterion to define the end-point renal dysfunction. A series of clinical and laboratory variables were obtained from the patients' charts at different time intervals, and their prognostic value for the occurrence of renal dysfunction was calculated by Cox proportional hazards models. 23 out of 114 patients reached the end point after a median time period of 21 months. High serum triglyceride, alanine aminotransferase, alkaline phosphatase, ciclosporin, urea, glucose, and hemoglobin levels were shown to be associated with the development of renal dysfunction. Four variables, i.e., triglyceride, ciclosporin, urea, and alkaline phosphatase, had an independent prognostic value. Our results confirm a role for ciclosporin in inducing renal dysfunction and identify hyperlipidemia and an increased plasma urea level as risk factors for renal dysfunction in heart transplant recipients. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [31] The Potential Role of IL-33 in Renal Transplant Recipients with Chronic Allograft Dysfunction
    Zhang, Jiexiu
    Wang, Zijie
    Xu, Zhen
    Han, Zhijian
    Tao, Jun
    Lu, Pei
    Huang, Zhengkai
    Zhou, Wanli
    Zhao, Chunchun
    Tan, Ruoyun
    Gu, Min
    [J]. ANNALS OF TRANSPLANTATION, 2016, 21 : 611 - 618
  • [32] L-arginine supplementation in young renal allograft recipients with chronic transplant dysfunction
    Zhang, XZ
    Ardissino, G
    Ghio, L
    Tirelli, AS
    Daccò, V
    Colombo, D
    Pace, E
    Testa, S
    Claris-Appiani, A
    [J]. CLINICAL NEPHROLOGY, 2001, 55 (06) : 453 - 459
  • [33] Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effects
    Abramowicz, Daniel
    Hadaya, Karine
    Hazzan, Marc
    Broeders, Nilufer
    Hoang, Anh-Dung
    Ghisdal, Lidia
    Noel, Christian
    Wissing, Karl Martin
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (11) : 3727 - 3729
  • [34] Chronic Allograft Dysfunction in Renal Transplantation
    Gurkan, Alp
    [J]. TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2008, 17 : 39 - 46
  • [35] Histopathology of chronic renal allograft dysfunction
    Furness, PN
    [J]. TRANSPLANTATION, 2001, 71 (11) : SS31 - SS36
  • [36] Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients
    Yuki Okushi
    Kazuaki Okino
    Kiyotaka Mukai
    Yuki Matsui
    Norifumi Hayashi
    Keiji Fujimoto
    Hiroki Adachi
    Hideki Yamaya
    Hitoshi Yokoyama
    [J]. Clinical and Experimental Nephrology, 2017, 21 : 932 - 940
  • [37] Oesophageal stasis is a risk factor for chronic lung allograft dysfunction and allograft failure in lung transplant recipients
    Ramendra, Rayoun
    Fernandez-Castillo, Juan C.
    Huszti, Ella
    Ghany, Rasheed
    Aversa, Meghan
    Havlin, Jan
    Riddell, Peter
    Chaparro, Cecilia M.
    Singer, Lianne G.
    Liu, Louis
    Keshavjee, Shaf
    Yeung, Jonathan C.
    Martinu, Tereza
    [J]. ERJ OPEN RESEARCH, 2023, 9 (05)
  • [38] Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients
    Okushi, Yuki
    Okino, Kazuaki
    Mukai, Kiyotaka
    Matsui, Yuki
    Hayashi, Norifumi
    Fujimoto, Keiji
    Adachi, Hiroki
    Yamaya, Hideki
    Yokoyama, Hitoshi
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (05) : 932 - 940
  • [39] RISK FACTORS FOR RENAL DYSFUNCTION FOLLOWING CARDIAC TRANSPLANTATION
    Lachance, K.
    Carrier, M.
    Mansour, A.
    Ducharme, A.
    Racine, N.
    Liszkowski, M.
    White, M.
    de Denus, S.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S281 - S281
  • [40] Risk Factors of Renal Dysfunction Following Cardiac Transplantation
    Lachance, K.
    Carrier, M.
    Mansour, A.
    Ducharme, A.
    Racine, N.
    Liszkowski, M.
    White, M.
    de Denus, S.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S258 - S258